1. Alexion Pharmaceuticals’ rare-disease drug Soliris netted another FDA approval for some patients with myasthenia gravis. Leerink Partners analyst Geoffrey Porges estimates that the new indication will bring in $1.2 billion in revenue over the next five years. (Endpoints News)
2. Sun Pharmaceutical Industries released a complimentary mobile app for its acne medication Absorica. The app allows patients to track their progress by regularly taking pictures of their skin. (MobiHealthNews)
3. Gilead Sciences CEO John Martin said in an interview that the general public wrongly believes that most of the money spent on healthcare goes to drugmakers. (WSJ)
4. AbbVie said it will partner with San Francisco-based biotech company Alector, which is trying to harness the body’s immune system to fight Alzheimer’s disease. (Reuters)
5. Hurricane Maria has halted manufacturing in certain factories used to make medical devices in Puerto Rico. Baxter Laboratories and Mylan are among the affected organizations. (NYT)
